News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Cryoport: Moving Toward Commercial Scalability And Near-Term Breakeven [Seeking Alpha]

CryoPort (CYRX) is now covered by Craig Hallum. They set a "buy" rating and a $15.00 price target on the stock.

CryoPort (CYRX) had its price target raised by Needham & Company LLC from $12.00 to $13.00. They now have a "buy" rating on the stock.

CryoPort Inc (CYRX) Q4 2025 Earnings Call Highlights: Record Growth in Cell and Gene Therapy Revenue [Yahoo! Finance]

CryoPort Q4 Earnings Call Highlights [Yahoo! Finance]

3/3/2026

04:05 pm

CYRX

2.9%

MISS

11/4/2025

04:05 pm

CYRX

-7.5%

BEAT

8/5/2025

04:19 pm

CYRX

29.8%

BEAT

5/7/2025

04:05 pm

CYRX

23.3%

MISS

Form 4 Cryoport, Inc. For: Apr 06 Filed by: SHELTON JERRELL

Form SCHEDULE 13G/A Cryoport, Inc. Filed by: VANGUARD GROUP INC

Form 4 Cryoport, Inc. For: Mar 23 Filed by: SHELTON JERRELL

Form 4 Cryoport, Inc. For: Mar 23 Filed by: STEFANOVICH ROBERT

Form 4 Cryoport, Inc. For: Mar 23 Filed by: Sawicki Mark W

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}